Aberrant expression of VASP serves as a potential prognostic biomarker and therapeutic target for oral squamous cell carcinoma.

Karpakavinayakam GopalakrishnanBalachander KannanChandra PandiAnitha PandiAbilasha RamasubramanianVijayashree Priyadharsini JayaseelanParamasivam Arumugam

Published in: Oral surgery, oral medicine, oral pathology and oral radiology (2024)

In conclusion, VASP emerges as a promising diagnostic and prognostic marker for OSCC within HNSCC, emphasizing the importance of exploring its regulatory mechanisms and therapeutic applications. The revealed pathways present avenues for targeted treatment in OSCC. Despite limitations, this study provides valuable insights with potential implications for improving patient outcomes.

Keyphrases

poor prognosis
human health
transcription factor
single cell
risk assessment
climate change
replacement therapy
smoking cessation